首页> 外国专利> compound and composition for use in the preventive and / or curative treatment of diseases of the central nervous system characterized by a decline in neuronal plasticity, in particular characterized by a decline in synaptic plasticity

compound and composition for use in the preventive and / or curative treatment of diseases of the central nervous system characterized by a decline in neuronal plasticity, in particular characterized by a decline in synaptic plasticity

机译:用于预防和/或治疗中枢神经系统疾病的化合物和组合物,其特征在于神经元可塑性下降,特别是特征在于突触可塑性下降

摘要

the present invention relates to a compound and composition for use in the preventive and / or curative treatment of diseases of the central nervous system which are distinguished by a decline in neuronal plasticity, in particular distinguished by a decline in synaptic plasticity. the present invention relates to a compound and composition for use in the preventive and / or curative treatment of diseases of the central nervous system which are distinguished by a decline in neuronal plasticity, in particular by a decline in synaptic plasticity, for example, in treatment of diseases of the central nervous system that affect cognitive processes such as: learning, perception, attention, reasoning, language and / or memory; in the treatment of diseases of the central nervous system such as: neurodegenerative diseases such as parkinson's, alzheimer's and / or amyotrophic lateral sclerosis; in the treatment of diseases of the central nervous system responsible for mood disorders, hyperexcitability, hyperactivity and / or stress; in the treatment of neurological disorders such as epilepsy, said compound being magnesium n-acetyl-taurinate.
机译:本发明涉及用于预防和/或治疗中枢神经系统疾病的化合物和组合物,其特征在于神经元可塑性下降,特别是突触可塑性下降。本发明涉及用于预防和/或治疗中枢神经系统疾病的化合物和组合物,其特征在于神经元可塑性下降,特别是突触可塑性下降,例如用于治疗影响认知过程的中枢神经系统疾病,例如:学习,知觉,注意力,推理,语言和/或记忆;用于治疗中枢神经系统疾病,例如:神经退行性疾病,例如帕金森氏症,老年痴呆症和/或肌萎缩性侧索硬化;在治疗引起情绪失调,过度兴奋,活动过度和/或压力的中枢神经系统疾病中;在神经系统疾病如癫痫的治疗中,所述化合物为正乙酰牛磺酸镁。

著录项

  • 公开/公告号BR112020007341A2

    专利类型

  • 公开/公告日2020-10-06

    原文格式PDF

  • 申请/专利权人 SYNAPHARM INDUSTRIAL SYNTHESIS;

    申请/专利号BR20201107341

  • 发明设计人 PASCALE AZZAM;PHILIPPE DANHIER;

    申请日2018-09-26

  • 分类号A61K31/185;A61K31/198;A61K31/4415;A61K31/51;A61K31/525;A61K33/06;

  • 国家 BR

  • 入库时间 2022-08-21 11:18:17

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号